Lakefront Biotherapeutics NV (LKFT) — Financial Flexibility Index
Lakefront Biotherapeutics NV (LKFT) has a Financial Flexibility Index of -0.69x as of March 2026. Free cash flow of $-82.63 Million (operating CF $-82.75 Million minus capex $123.00K) represents -1% of total liabilities ($119.06 Million). For the full cash flow conversion analysis, see LKFT cash generation efficiency.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Lakefront Biotherapeutics NV Financial Flexibility Index (2022–2025)
Historical Financial Flexibility Index trend for Lakefront Biotherapeutics NV across 4 annual periods. Check LKFT tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Annual Financial Flexibility Index for Lakefront Biotherapeutics NV (2022–2025)
Year-by-year free cash flow to debt coverage for Lakefront Biotherapeutics NV. Explore Lakefront Biotherapeutics NV (LKFT) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.43x | $-243.60 Million | $-257.46 Million | $170.65 Million | ▼ -643.3% |
| 2024 | -0.19x | $-237.92 Million | $-320.03 Million | $1.24 Billion | ▲ +22.4% |
| 2023 | -0.25x | $-386.70 Million | $-405.97 Million | $1.56 Billion | ▼ -17.9% |
| 2022 | -0.21x | $-463.60 Million | $-500.54 Million | $2.21 Billion | — |